Building upon our previous successes in addressing immune tolerance in osteoporosis vaccine development (10), we propose a novel vaccine strategy that integrates the SOST protein with a diphtheria toxin translocation domain (DTT) as an adjuvant scaffold. The gene discussed is SOST; the disease is osteoporosis.